Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 58 min 10 sec ago

Latest Data Shows OrbusNeich's COMBO(TM) Dual Therapy Stent has Excellent Healing Benefits

Thu, 09/18/2014 - 16:28
The world's first and only dual therapy stent WASHINGTON, Sept. 18, 2014 -- (Healthcare Sales & Marketing Network) --Prof. Stephen W.L. Lee presented two-year optical coherence tomography (OCT) findings and three-year clinical follow up from the EGO CO...
Devices, Interventional Cardiology
OrbusNeich, Dual Therapy Stent, drug eluting stent

NOXXON Pharma Expands Management Team by Appointing Don Munoz as Chief Financial Officer

Thu, 09/18/2014 - 16:24
Appointment initiates a US presence in the Boston area BERLIN & BOSTON--(Healthcare Sales & Marketing Network)--NOXXON Pharma has appointed Don Munoz to the newly created position of Chief Financial Officer. Mr. Munoz will strengthen the executive manag...
Biopharmaceuticals, Personnel
NOXXON Pharma, Spiegelmers

Evotec Takes Legal Steps Against Andromeda Biotech, Ltd.

Thu, 09/18/2014 - 16:21
HAMBURG, Germany, Sept. 18, 2014 -- (Healthcare Sales & Marketing Network) -- Evotec AG (EVT.F) (TecDAX) (ISIN:DE0005664809) announced today after careful evaluation that it will take legal steps against Israel-based Andromeda Biotech, Ltd. ("Andromed...
Biopharmaceuticals, Litigation
Evotec, Andromeda Biotech, DiaPep277

Integra LifeSciences to Acquire Medtronic's MicroFrance and Xomed Manual ENT and Laparoscopy Instrumentation Lines

Wed, 09/17/2014 - 12:58
PLAINSBORO, N.J., Sept. 17, 2014 -- (Healthcare Sales & Marketing Network) -- Integra LifeSciences Holdings Corporation (IART) and Medtronic, Inc. today announced an agreement in which Integra will acquire Medtronic's MicroFrance and Xomed manual ENT and l...
Devices, Acquisitions
Integra LifeSciences, Medtronic, MicroFrance, Xomed

Ivera Medical Files Patent Infringement Case Against Catheter Connections and CTI for Sales of Light Blue DualCap IV Pole Strips

Wed, 09/17/2014 - 12:50
SAN DIEGO, CA--(Healthcare Sales & Marketing Network) - Ivera Medical announced that it has filed a new patent infringement case against Catheter Connections and its Ohio-based distributor, Clinical Technology Inc., based on sales of their Light Blue DualC...
Devices, Litigation
Ivera Medical, Catheter Connections, Curos Strip

CTI BioPharma And Servier Announce Exclusive License And Collaboration Agreement To Develop And Commercialize PIXUVRI(R)

Wed, 09/17/2014 - 12:36
Total Deal Valued at up to Approximately $133.5 Million; Approximately $18.1 million Upfront CTI Retains 100% Commercialization Rights to PIXUVRI in U.S. and Certain E.U. Territories Conference Call Scheduled for Today at 8:30 a.m. EDT SEATTLE, S...
Biopharmaceuticals, Oncology, Licensing
CTI BioPharma, Servier, PIXUVRI, pixantrone, B-cell NHL

Boston Scientific Receives CE Mark For The Vercise(TM) Deep Brain Stimulation (DBS) System For Treating Patients With Tremor

Wed, 09/17/2014 - 12:26
Vercise DBS System is the First DBS System Offering Precise Neural Targeting and a 25-Year Battery Life MARLBOROUGH, Mass., Sept. 17, 2014 -- (Healthcare Sales & Marketing Network) -- Boston Scientific Corporation (BSX) has received CE Mark for the Ver...
Devices, Neurosurgery, Regulatory
Boston Scientific, Vercise, Deep Brain Stimulation, essential tremor

Dimension Therapeutics Names Annalisa Jenkins as Chief Executive Officer

Tue, 09/16/2014 - 13:11
CAMBRIDGE, Mass.--(Healthcare Sales & Marketing Network)--Dimension Therapeutics, a gene therapy company focused on developing novel treatments for rare diseases, today announced that Annalisa Jenkins, MBBS, MRCP has been appointed as chief executive offic...
Biopharmaceuticals, Personnel
Dimension Therapeutics, gene therapy

Synereca Pharmaceuticals Announces Financing Led by Accele Venture Partners

Tue, 09/16/2014 - 13:08
Funding to Support Development of New Treatments for Drug-Resistant Gram-Negative Bacterial Infections OKLAHOMA CITY, Sept. 16, 2014 -- (Healthcare Sales & Marketing Network) -- Synereca Pharmaceutics, Inc. (SPI), a research-stage biopharmaceutical com...
Biopharmaceuticals, Venture Capital
Synereca Pharmaceutics

First-In-Man Study of the COBRA PzF(TM) Coronary Stent Shows Promising Results Highlighted by Short, 30-Day Dual-Antiplatelet Therapy and Low, 3% TLR Rate

Tue, 09/16/2014 - 13:02
WASHINGTON--(Healthcare Sales & Marketing Network)--CeloNova BioSciences, Inc., today announced that positive First-in-Man (FIM) clinical trial results found its COBRA PzF™ coronary stent system with an advanced nano-thin coating of Polyzene®-F polymer...
Devices, Interventional Cardiology
CeloNova BioSciences, COBRA PzF, coronary stent, Polyzene-F

OncoSec Medical Appoints Dr. Mai H. Le to Position of Chief Medical Officer and Names Dr. Robert H. Pierce as Chief Scientific Officer

Tue, 09/16/2014 - 12:57
Dr. Le to Oversee OncoSec’s Clinical Development and Regulatory Programs; Dr. Pierce to Grow R&D Pipeline SAN DIEGO--(Healthcare Sales & Marketing Network)--OncoSec Medical Inc. (OTCQB: ONCS), a company developing DNA-based intratumoral cancer immunothe...
Biopharmaceuticals, Personnel
OncoSec Medical, ImmunoPulse

Venture Backed Catheter Connections Continues to Make False Statements, According to Ivera Medical

Tue, 09/16/2014 - 12:51
SAN DIEGO, CA--(Healthcare Sales & Marketing Network) - In a press release dated September 12, 2014, Catheter Connections continued its pattern of misrepresentation, omission of key facts, and false statements. While the court in Salt Lake City did issue t...
Ivera Medical, Catheter Connections, Curos Tips

NovaBiotics Receives Orphan Drug Status from the US Food and Drug Administration (FDA) for Lynovex(R) for the Treatment of Cystic Fibrosis

Tue, 09/16/2014 - 12:45
Orphan drug designation coincides with dosing of first patients in PhIIa study ABERDEEN, Scotland--(Healthcare Sales & Marketing Network)--NovaBiotics Ltd, the Aberdeen-based clinical-stage biotechnology company (“NovaBiotics” or the “Company”), today a...
Biopharmaceuticals, FDA
NovaBiotics, Lynovex, Cystic Fibrosis, orphan drug designation

Bayer and Orion Initiate Phase III Trial of ODM-201 in Men with High-Risk Non-Metastatic Castration-Resistant Prostate Cancer

Tue, 09/16/2014 - 12:39
WHIPPANY, N.J., Sept. 16, 2014 -- (Healthcare Sales & Marketing Network) -- Bayer HealthCare and Orion Corporation, a pharmaceutical company based in Espoo, Finland, have begun to enroll patients in a Phase III trial with ODM-201, an investigational oral ...
Biopharmaceuticals, Oncology
Bayer HealthCare Pharmaceuticals, Orion Corporation, prostate cancer

Sotera(R) Wireless Names Charlie Alvarez To Lead Sales And Marketing

Mon, 09/15/2014 - 16:04
SAN DIEGO, Sept. 15, 2014 -- (Healthcare Sales & Marketing Network) -- Sotera® Wireless today announced that industry veteran Charlie Alvarez has been appointed senior vice president of sales and marketing. Alvarez will lead the Company's strategic i...
Devices, Monitoring, Personnel
Sotera Wireless

Antares Pharma Announces Promotion of Robert F. Apple to Chief Operating Officer

Mon, 09/15/2014 - 11:20
EWING, N.J.--(Healthcare Sales & Marketing Network)--Antares Pharma, Inc. (ATRS) today announced that Robert F. Apple has been promoted to Chief Operating Officer effective immediately. The Company also announced that a retained search has begun to fill th...
Biopharmaceuticals, Personnel
Antares Pharma, OTREXUP, methotrexate, rheumatoid arthritis

Retina Implant AG's International Clinical Results Presented for the First Time in Europe

Mon, 09/15/2014 - 11:16
Professor Eberhart Zrenner Leads Discussion of Alpha IMS Patient Results One Year Post Implantation at Europe's Largest Ophthalmology Conference LONDON, Sept. 15, 2014 -- (Healthcare Sales & Marketing Network) -- Retina Implant AG, the leading develope...
Devices, Ophthalmology
Retina Implant AG, retinitis pigmentosa, Alpha IMS

Volcano to Showcase Two Novel Commercial Products at TCT 2014: SyncVision(R), and the iFR(R) Modality

Fri, 09/12/2014 - 13:01
Release of these novel precision guidance tools will be demonstrated in live cases, symposia and training programs throughout the week SAN DIEGO, Sept. 12, 2014 -- (Healthcare Sales & Marketing Network) -- Volcano Corporation (VOLC), a leading company ...
Devices, Interventional Cardiology
Volcano, coronary imaging, SyncVision

Symetis Receives CE Mark Approval for Transfemoral Transcatheter Aortic Heart Valve System ACURATE neo(TM), and Launches Product With First Commercial Implantations

Fri, 09/12/2014 - 12:54
Symetis Joins Industry Leaders Edwards Lifesciences and Medtronic as Only Companies to Offer Both Transapical and Transfemoral Options for Transcatheter Aortic Heart Valve Delivery LAUSANNE, SWITZERLAND--(Healthcare Sales & Marketing Network) - Symetis ...
Devices, Interventional Cardiology, Product Launch
Symetis, ACURATE neo, transfemoral TAVI, TAVI

Michael C. Kaufmann to Become Chief Financial Officer of Cardinal Health; Jon Giacomin to Lead Pharmaceutical Segment

Thu, 09/11/2014 - 16:55
DUBLIN, Ohio, Sept. 11, 2014 -- (Healthcare Sales & Marketing Network) -- Cardinal Health announced today that Michael C. Kaufmann, 51, has been named chief financial officer of the company effective Nov. 11, 2014. This follows the previously announced pl...
Biopharmaceuticals, Devices, Personnel
Cardinal Health

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong